Vascularized lymph node transfer (VLNT) versus lymphaticovenous anastomosis (LVA) for chronic breast cancer-related lymphedema (BCRL): a retrospective cohort study of effectiveness over time

VLNT and LVA are both effective in long-term lymphedema management, yet they demonstrate marked differences in the timing of improvement. VLNT shows a delayed but more durable response, in contrast to the greater but shorter-lasting surge in effectiveness achieved by LVA. Interestingly, VLNT demonstrates an earlier onset of therapeutic impact than previously understood.

Authors

Institutions

Publication Details

Journal
Breast Cancer Research and Treatment
Published
2024-12-10
DOI
https://doi.org/10.1007/s10549-024-07567-5
Citations
7
Primary Topic
Lymphatic System and Diseases
Type
article
Field-Weighted Citation Impact
1.98

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vascularized lymph node transfer (VLNT) versus lymphaticovenous anastomosis (LVA) for chronic breast cancer-related lymphedema (BCRL): a retrospective cohort study of effectiveness over time

Christoph Andree, Sonia Fertsch, Florian Samuel Halbeisen, Martin Haug et al.
7 citations
Breast Cancer Research and Treatment
Lymphatic System and Diseases
1.98
article

Vascularized lymph node transfer (VLNT) versus lymphaticovenous anastomosis (LVA) for chronic breast cancer-related lymphedema (BCRL): a retrospective cohort study of effectiveness over time

Christoph Andree, Sonia Fertsch, Florian Samuel Halbeisen, Martin Haug, Julia Bukowiecki, Dirk J. Schaefer, Elisabeth A. Kappos, Tristan M Handschin, Alina Abu-Ghazaleh, Birgit Aufmesser-Freyhardt, K Seidenstücker, Adriano Fabi, Julia Stoffel
article en
7 citations

Abstract

VLNT and LVA are both effective in long-term lymphedema management, yet they demonstrate marked differences in the timing of improvement. VLNT shows a delayed but more durable response, in contrast to the greater but shorter-lasting surge in effectiveness achieved by LVA. Interestingly, VLNT demonstrates an earlier onset of therapeutic impact than previously understood.

Breast Cancer Research and TreatmentVol. 210(2)
Witten/Herdecke University (DE), University of Basel (CH), University of Zurich (CH), University Hospital of Basel (CH), Düsseldorf University Hospital (DE), Sana Kliniken AG (DE), Heinrich Heine University Düsseldorf (DE)
National Science Foundation, Freiwillige Akademische Gesellschaft, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Swiss Cancer Research Foundation, Rising Tide Foundation
Good health and well-being
Openalex Percentile: Top 11%
Lymphatic System and Diseases
1.98
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.